New approaches to cyclosporine monitoring raise further concerns about analytical techniques.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 10839783)

Published in Clin Chem on June 01, 2000

Authors

D W Holt1, A Johnston, B D Kahan, R G Morris, M Oellerich, L M Shaw

Author Affiliations

1: St. George's Hospital Medical School, London, United Kingdom.

Articles by these authors

(truncated to the top 100)

Place navigation impaired in rats with hippocampal lesions. Nature (1982) 15.79

Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72

Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci (2000) 8.20

Synaptic tagging and long-term potentiation. Nature (1997) 7.65

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature (1986) 7.10

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67

Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature (1998) 6.29

Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69

Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43

STRIPE: an interactive computer program for the analysis of drug pharmacokinetics. J Pharmacol Methods (1983) 4.64

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51

Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72

Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus (1999) 3.55

Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci U S A (1995) 3.42

Ethylene glycol poisoning: toxicokinetic and analytical factors affecting laboratory diagnosis. Clin Chem (1998) 3.32

Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology (2001) 3.30

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature (2001) 3.28

Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci (2004) 3.10

Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci (1998) 3.00

Memory consolidation and NMDA receptors: discrepancy between genetic and pharmacological approaches. Science (2001) 2.97

Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet (1978) 2.86

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85

MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83

Fine needle aspiration cytology in the management of a parotid mass: a two centre retrospective study. Surgeon (2005) 2.77

Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology (1985) 2.77

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology (2010) 2.67

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet (1993) 2.66

Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (1976) 2.65

The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54

Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49

Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature (1995) 2.47

White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology (2006) 2.42

Mouse egg integrin alpha 6 beta 1 functions as a sperm receptor. Cell (1995) 2.32

Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci (1999) 2.32

Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain (2003) 2.32

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32

Volume and outcome in hospital care: evidence, explanations and implications. Health Serv Manage Res (1990) 2.28

Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med (1999) 2.20

Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20

Salt extraction of soluble HL-A antigens. Science (1971) 2.18

Impaired spatial learning after saturation of long-term potentiation. Science (1998) 2.17

Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words. Nat Neurosci (2002) 2.05

Hippocampal representation in place learning. J Neurosci (1990) 2.05

Violent injuries among women in an urban area. N Engl J Med (1999) 2.04

Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol (1982) 2.04

The enigma of olfactory learning. Trends Neurosci (1993) 2.02

Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp (1999) 2.01

A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol Aging (2007) 1.92

Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology (2010) 1.89

Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89

Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia (1989) 1.87

Categorizing sex and identity from the biological motion of faces. Curr Biol (2001) 1.87

cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem (2001) 1.87

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86

Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation (1985) 1.83

Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol (1984) 1.83

Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol (2004) 1.82

Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res (2000) 1.80

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab (2001) 1.78

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75

The functional neuroanatomy of comprehension and memory: the importance of prior knowledge. Brain (1999) 1.74

Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry (2004) 1.72

The alpha 6 beta 4 integrin and epithelial cell migration. Curr Opin Cell Biol (2001) 1.71

Transplantation antigens. Adv Immunol (1970) 1.70

Landmark stability is a prerequisite for spatial but not discrimination learning. Nature (1993) 1.66

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation (2002) 1.64

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology (2010) 1.63

A multichamber equilibrium dialysis apparatus. Anal Biochem (1972) 1.61

Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions. Exp Brain Res (1985) 1.59

Minimally invasive late free flap salvage: indications, efficacy and implications for reconstructive microsurgeons. J Plast Reconstr Aesthet Surg (2011) 1.59

Weak before strong: dissociating synaptic tagging and plasticity-factor accounts of late-LTP. Neuropharmacology (1999) 1.57

Line transect methods for plant surveys. Biometrics (2007) 1.55

The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci (1992) 1.54

Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function. Q J Exp Psychol B (1986) 1.53

High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene (1989) 1.52

The underreporting of cocaine-related trauma: drug abuse warning network reports vs hospital toxicology tests. Am J Public Health (1993) 1.52

Plasma nitrate concentrations in children with infectious and noninfectious diarrhea. J Pediatr Gastroenterol Nutr (2001) 1.51

Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51

En bloc transplantation of kidneys from pediatric donors. J Urol (1996) 1.51

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51

Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects. Aliment Pharmacol Ther (2012) 1.50

Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene (1993) 1.50

Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacol Res (2010) 1.50

A model of hippocampally dependent navigation, using the temporal difference learning rule. Hippocampus (2000) 1.50

Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. J Cell Biol (1998) 1.50

MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene (1991) 1.49

Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. Arthritis Rheum (1997) 1.48

Brief cognitive assessment for patients with cerebral small vessel disease. J Neurol Neurosurg Psychiatry (2005) 1.47

The synergistic effects of cyclosporine and sirolimus. Transplantation (1997) 1.47

The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J Biol Chem (1990) 1.47

Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer (1987) 1.45

Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J (1988) 1.45

Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc (1988) 1.44

Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Brain (1996) 1.44

Ranitidine, cimetidine, and the cyclosporine-treated recipient. Transplantation (1986) 1.44

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol (1997) 1.43

Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group. Transplantation (1999) 1.42

HLA matching assessed from early graft function. Transplant Proc (1987) 1.40